Shop by goal

Popular compounds

Research resources

IGF-1 LR3: Muscle / Performance research guide

Q: What is IGF-1 LR3?

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is an 83-amino-acid analogue of human IGF-1 with an N-terminal extension and an Arg substitution at position 3. Those modifications stop it binding IGF-binding proteins, greatly extending its active half-life versus native IGF-1. It is supplied as a lyophilised research-grade powder for laboratory use only.

Q: What does IGF-1 LR3 do?

In research models IGF-1 LR3 activates the IGF-1 receptor (and PI3K/Akt and MAPK signalling) to drive cell growth, proliferation, differentiation and survival — with a much longer duration of action than native IGF-1 because it evades IGFBP sequestration. These are findings in cell and animal models; New-U supplies it for laboratory research only and implies no human effect.

Q: What is IGF-1 LR3 used for?

IGF-1 LR3 is widely used as a cell-culture supplement to support proliferation and survival of cultured cells, and as a research tool for studying IGF-1-receptor signalling, hypertrophy and tissue-growth endpoints. New-U supplies it strictly for in-vitro and laboratory research; it is not for human use.

Q: Does IGF-1 LR3 show up on a drug test?

Standard employment or clinical drug panels (including typical LabCorp steroid panels) do not screen for IGF-1 LR3 — it is a peptide, not a small-molecule steroid, and requires specialised assays. It is, however, on the WADA Prohibited List, and anti-doping authorities use dedicated tests for IGF-1 analogues. New-U supplies IGF-1 LR3 for laboratory research only, not for human or athletic use.

Q: What does "LR3" actually mean?

"L" for the 13-amino-acid N-terminal extension (MFPAMPLSSLFVN), "R" for arginine, and "3" for position 3 of the IGF-1 sequence. So "LR3" literally means "the Long variant with an Arginine at position 3". Both modifications are needed to eliminate IGFBP binding and extend circulating half-life.

Q: How is IGF-1 LR3 different from IGF-1 DES?

IGF-1 DES is the opposite end of the design spectrum - a truncated 67-residue form missing the N-terminal tripeptide GPE, which also dramatically reduces IGFBP binding. IGF-1 LR3 uses a 13-residue extension to achieve similar IGFBP resistance. LR3 has a much longer half-life (20-30 h vs minutes); DES produces more intense, shorter-duration local effects when injected site-specifically.

Q: Why is IGF-1 LR3 used in cell culture?

Native IGF-1 is inefficient in cell culture because IGFBPs produced by the cells themselves can sequester it, reducing effective concentrations. IGF-1 LR3 escapes that sequestration and delivers consistent, reproducible growth-factor signalling. That is why it is an industry standard for bioprocessing and mammalian cell culture.

Q: How should IGF-1 LR3 be stored?

Keep the lyophilised powder frozen at −20 °C (−80 °C for long-term storage). After reconstitution, refrigerate at 1-6 °C and protect from light. IGF-1 LR3 is a structured protein and is sensitive to repeated freeze-thaw cycles - aliquot if you need multiple aliquots from one reconstitution.

Q: How is IGF-1 LR3 reconstituted in the lab?

Because IGF-1 LR3 is a structured protein that tends to aggregate in neutral aqueous solution, laboratory practice commonly reconstitutes it in dilute acetic acid (around 0.1%, ~10 mM) rather than plain water, which keeps it in a non-aggregated state; bacteriostatic or sterile water is also used. The vial is allowed to reach room temperature before opening to avoid condensation, then gently rolled rather than shaken. This is general handling guidance for research material, not a dosing instruction.

Q: Is this page medical advice? Can I use IGF-1 LR3 for my health?

No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

Not medical advice. IGF-1 LR3 is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.

What IGF-1 LR3 is

IGF-1 LR3 is investigated for IGF-receptor signalling, muscle cell culture work, and growth-factor cascades downstream of GH.

One-paragraph overview from our research datasheet — still scientific, but faster to read than the full mechanism list below.

IGF-1 LR3, 83-amino acid extended IGF-1 analogue with Arg3 substitution eliminating IGFBP binding for 3-fold enhanced potency and 20–30 hour half-life.

Quick takeaways

Long half-life variants are tools in cell biology rather than “recovery shortcuts” in humans.

Research contexts

Peer-reviewed literature typically discusses IGF-1 LR3 in specific experimental settings. The points below reflect how the scientific community frames this compound—not as health claims, but as the research questions being asked.

Research vs. personal use: Literature describes experiments in controlled lab and animal models. This is distinct from any real-world use; our products are for laboratory research only.

Typical study contexts

Cell-culture papers use LR3 variants to maintain IGF receptor stimulation across longer incubations, an assay convenience, not a human protocol.

Animal work may examine muscle regeneration models; results are species- and model-specific.

Muscle injury, overload, or culture models examining growth-factor cascades and repair timelines.

IGF/IGFBP biology in cell lines and animals where the question is signalling, not “gains” in people.

Peer-reviewed preclinical work sometimes describes experiments that track whether arg3 substitution eliminates IGFBP binding increasing free bioavailable IGF-1 approximately 3-fold

Peer-reviewed preclinical work sometimes describes experiments that track whether 13-amino acid N-terminal extension enhances metabolic stability extending half-life to 20–30 hours

Peer-reviewed preclinical work sometimes describes experiments that track whether full IGF-1R agonist activating PI3K/Akt/mTOR protein synthesis and RAS/RAF/MEK/ERK proliferation pathways

Peer-reviewed preclinical work sometimes describes experiments that track whether bypasses hepatic GH/JAK2/STAT5 axis, direct peripheral tissue receptor activation

Why Muscle / Performance research matters

Here the literature centres on muscle repair, growth-factor signalling, and how tissues respond after overload or injury in preclinical work.

Mechanisms (technical review)

Our datasheet lists mechanistic themes observed in preclinical work. These are research endpoints, not health claims. They help scientists understand and compare pathways.

Arg3 substitution eliminates IGFBP binding increasing free bioavailable IGF-1 approximately 3-fold

13-amino acid N-terminal extension enhances metabolic stability extending half-life to 20–30 hours

Full IGF-1R agonist activating PI3K/Akt/mTOR protein synthesis and RAS/RAF/MEK/ERK proliferation pathways

Bypasses hepatic GH/JAK2/STAT5 axis, direct peripheral tissue receptor activation

Promotes hyperplasia (new muscle cell formation) and mitogenesis via satellite cell activation

Counteracts myostatin signaling through MyoD pathway activation in Duchenne muscular dystrophy models

Lab handling & preparation

Storage requirements: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation. · Learn best practices in our detailed storage guide.

Research dosing context: Literature typically discusses 20–100 mcg subcutaneously or intramuscularly · Once daily, typically post-training or divided bilateral injections · t½ ≈ 20–30 h (vs. 12–15 h for native IGF-1); enhanced bioavailability due to <2% IGFBP binding (vs. ~98% for native IGF-1); produced via recombinant E. coli expression with chromatographic purification and refolding. Not FDA-approved, mecasermin (native rhIGF-1) is approved for pediatric primary IGFD. Banned by WADA.

Preparation steps: Follow our detailed reconstitution guide, use the calculator tool for volume confirmation, and always verify purity with the COA reading guide.

Common Questions People Are Asking

What is IGF-1 LR3?

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is an 83-amino-acid analogue of human IGF-1 with an N-terminal extension and an Arg substitution at position 3. Those modifications stop it binding IGF-binding proteins, greatly extending its active half-life versus native IGF-1. It is supplied as a lyophilised research-grade powder for laboratory use only.

What does IGF-1 LR3 do?

In research models IGF-1 LR3 activates the IGF-1 receptor (and PI3K/Akt and MAPK signalling) to drive cell growth, proliferation, differentiation and survival — with a much longer duration of action than native IGF-1 because it evades IGFBP sequestration. These are findings in cell and animal models; New-U supplies it for laboratory research only and implies no human effect.

What is IGF-1 LR3 used for?

IGF-1 LR3 is widely used as a cell-culture supplement to support proliferation and survival of cultured cells, and as a research tool for studying IGF-1-receptor signalling, hypertrophy and tissue-growth endpoints. New-U supplies it strictly for in-vitro and laboratory research; it is not for human use.

Does IGF-1 LR3 show up on a drug test?

Standard employment or clinical drug panels (including typical LabCorp steroid panels) do not screen for IGF-1 LR3 — it is a peptide, not a small-molecule steroid, and requires specialised assays. It is, however, on the WADA Prohibited List, and anti-doping authorities use dedicated tests for IGF-1 analogues. New-U supplies IGF-1 LR3 for laboratory research only, not for human or athletic use.

What does "LR3" actually mean?

"L" for the 13-amino-acid N-terminal extension (MFPAMPLSSLFVN), "R" for arginine, and "3" for position 3 of the IGF-1 sequence. So "LR3" literally means "the Long variant with an Arginine at position 3". Both modifications are needed to eliminate IGFBP binding and extend circulating half-life.

How is IGF-1 LR3 different from IGF-1 DES?

IGF-1 DES is the opposite end of the design spectrum - a truncated 67-residue form missing the N-terminal tripeptide GPE, which also dramatically reduces IGFBP binding. IGF-1 LR3 uses a 13-residue extension to achieve similar IGFBP resistance. LR3 has a much longer half-life (20-30 h vs minutes); DES produces more intense, shorter-duration local effects when injected site-specifically.

Why is IGF-1 LR3 used in cell culture?

Native IGF-1 is inefficient in cell culture because IGFBPs produced by the cells themselves can sequester it, reducing effective concentrations. IGF-1 LR3 escapes that sequestration and delivers consistent, reproducible growth-factor signalling. That is why it is an industry standard for bioprocessing and mammalian cell culture.

How should IGF-1 LR3 be stored?

Keep the lyophilised powder frozen at −20 °C (−80 °C for long-term storage). After reconstitution, refrigerate at 1-6 °C and protect from light. IGF-1 LR3 is a structured protein and is sensitive to repeated freeze-thaw cycles - aliquot if you need multiple aliquots from one reconstitution.

How is IGF-1 LR3 reconstituted in the lab?

Because IGF-1 LR3 is a structured protein that tends to aggregate in neutral aqueous solution, laboratory practice commonly reconstitutes it in dilute acetic acid (around 0.1%, ~10 mM) rather than plain water, which keeps it in a non-aggregated state; bacteriostatic or sterile water is also used. The vial is allowed to reach room temperature before opening to avoid condensation, then gently rolled rather than shaken. This is general handling guidance for research material, not a dosing instruction.

Is this page medical advice? Can I use IGF-1 LR3 for my health?

No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

Where do I find IGF-1 LR3 specs, purity certificates and pricing?

Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.

Related peptide guides

Other compounds researchers often read about alongside IGF-1 LR3.

PEG-MGF - companion guide

MGF - companion guide

TB-500 - companion guide

BPC-157 - companion guide

Scientific sources & further reading

Primary literature and registries for IGF-1 LR3, plus mainstream coverage of the peptide category. Research use only - not medical advice.

Databases & literature:

PubMed: peer-reviewed literature on IGF-1 LR3

ClinicalTrials.gov: registered studies on IGF-1 LR3

IGF-1 LR3: Wikipedia

Peptides in the news:

WebMD: consumer health reference

BBC News: Health

CNN Health: “Peptides: what to know about the wellness trend”

Sky News: “Can peptides make America healthy again?”

Sky News: “Inside the exploding US peptides craze” (video)

Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”

Sky News Australia: “Backyard peptide boom sparks alarm” (video)

Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”

Ready to order? View full product specs

Access concentration, batch info, variants, and current pricing on our shop.

Also known as: Long R3 IGF-1, Long Arginine 3 IGF-1, IGF-1 LR3, LR3-IGF-1, Insulin-Like Growth Factor 1 Long R3, LONG R3 IGF-I, Recombinant Long R3 IGF-1

Premium research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical with a Certificate of Analysis on every lot. Shipped lab-direct, discreet and cold-chain, worldwide. For laboratory research use only.

Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.

Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.

Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.